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Certain fatty acids function as signaling molecules. HODEs are stable oxidation products 
of linoleic acid (LA; C18:2), are abundant in atherosclerotic plaque, and known to signal 
through GPR132 (9-HODE only) or PPARgamma (9-HODE and 13-HODE). 
Macrophage apoptosis is an important process, contributing to atherosclerosis 
progression. Both GPR132 and PPARgamma were expressed in THP1 (RT-PCR and 
immunohistochemistry) with expression of both increased when cells were differentiated 
into macrophages (PMA). In 24-hour cultures, 9-HODE but not 13-HODE or LA 
decreased cell number (68%, p<0.001). We aimed to determine whether this was due to 
apoptosis and how it was mediated. Using a caspase 3/7 assay, 9-HODE and 13-HODE 
(30-100mM) but not LA increased caspase activity in monocytes and macrophages, with 
9-HODE being more potent (p<0.001). This was accompanied by decreased cell viability 
(ATP generation assay, both p<0.001). FACS was used to quantify cells that were either 
viable or apoptotic (7AAD and annexin V positive). There was a time-dependent (over 24 
hours) increase in apoptotic cells with 9-HODE and 13-HODE (both p<0.001), with 9-
HODE being more potent (p<0.001). The effect of HODEs was replicated with 
campothecin (10mM) but not with the PPARgamma agonist rosiglitazone (1mM). The 
pro-apoptotic effects of HODEs were abolished by addition of the caspase inhibitor 
DEVA-CHO but not affected by the PPARgamma antagonist T0070907. In a gel-based 
assay, DNA fragmentation was apparent with campothecin and 9-HODE but not with LA 
or 13-HODE. GPR132 expression was silenced using siRNA oligonucleotides. There was 
no evidence of decreased effect of either 9-HODE or 13-HODE with GPR132 silencing. 
In conclusion, HODEs, and particularly 9-HODE, are potent regulators of macrophage 
apoptosis. They do not appear to be signaling through GPR132 or PPARgamma, both of 
which have regulatory roles in atherosclerosis. Further study of their mode of action may 
lead to identification of novel therapeutic targets for atherosclerosis.  
 
 
 
 
 
 
 
